Startup | May 04, 2026
HealthFab raises Rs 20 crore in Series A funding from Atomic Capital
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
Certification reinforces energy efficiency, sustainability goals, and green manufacturing across SMT’s Surat and Hyderabad facilities
The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
The approval was driven by data from the Phase III TULIP-SC trial
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones
Subscribe To Our Newsletter & Stay Updated
